ask="42.90"
ask_size="100"
average_daily_volume="1288520"
bid="40.00"
bid_size="700"
book_value="11.83"
change="+0.25"
change_from_200_day_moving_average="-10.13"
change_from_50_day_moving_average="2.73"
change_from_52_week_high="-37.10"
change_From_52_week_low="11.63"
change_in_percent="+0.58%"
close="43.01"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.82"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-4.94"
ex_dividend_date="N/A"
float_shares="70877000"
high="43.15"
high_52_weeks="80.11"
last_trade_date="2/6/2017"
last_trade_price="43.01"
last_trade_size="84088"
last_trade_time="4:00pm"
low="42.32"
low_52_weeks="31.38"
market_capitalization="3.69B"
moving_average_200_day="53.14"
moving_average_50_day="40.28"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="64.33"
open="42.61"
pe_ratio="N/A"
peg_ratio="-0.19"
percent_change_from_200_day_moving_average="-19.07%"
percent_change_from_50_day_moving_average="+6.78%"
percent_change_from_52_week_high="-46.31%"
percent_change_from_52_week_low="+37.06%"
previous_close="42.76"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.61"
price_per_sales="98.49"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="8.69"
stock_exchange="NMS"
symbol="ALNY"
volume="702139"
weeks_range_52="31.38 - 80.11"
